Impact of GPT-4–Generated Discharge Letters on Patients’ Medical Comprehension: Prospective Crossover Study
Journal of Medical Internet Research · 2026-02-26 · 28 · e81243
DOI: 10.2196/81243 ↗At a glance
Randomisierte kontrollierte Studie in Journal of Medical Internet Research, published online on 2026-02-26. Written by Friederike Holderried and 9 co-authors. Institution: Tübingen Institute for Medical Education (TIME), University of Tübingen, Tübingen, Germany. Major MEDLINE topics: Patient Discharge, Comprehension. Cited 8 times so far (Crossref); 65 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Patients often struggle to understand standard hospital discharge letters, increasing the risk of medication errors and misunderstandings. According to cognitive load theory (CLT), complex, information-dense texts can overload working memory and impair comprehension. Artificial intelligence tools that generate patient-centered versions could help reduce extraneous cognitive load and bridge this gap. However, evidence for their effectiveness remains limited.
Objective
This study aimed to evaluate whether GPT-4 (OpenAI)–generated patient-centered letters improve standardized patients’ retention and understanding of safety-relevant medical information compared with standard hospital discharge letters, and to explore potential effects on cognitive load as described by CLT.
Methods
In this prospective, randomized, crossover study, 48 trained standardized patients received a conventional discharge letter for an assigned disease (out of 3) and its matching GPT-4–generated patient-centered letter. Participants read one version first, identified predefined safety-relevant “learning objectives,” and then repeated the task with the alternate version. The primary outcome was the proportion of learning objectives fully, partially, or not reported. In a secondary analysis, results were stratified by content field (Medication, Organization, Prevention of Complications, Lifestyle/Disease Management) and Bloom taxonomy level (“Remember,” “Understand”).
Results
The letter type significantly influenced comprehension (odds ratio [OR] 1.74, 95% CI 1.45-2.08; P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Tübingen Institute for Medical Education (TIME), University of Tübingen, Tübingen, Germany.
- Department of Psychiatry and Psychotherapy, University of Erlangen-Nürnberg, Erlangen, Germany.
- Nephrological Center Villingen-Schwenningen, Villingen-Schwenningen, Germany.
- Department of Diabetology, Endocrinology, Nephrology, University of Tübingen, Tübingen, Germany.
- Karlsruhe Municipal Hospital, Karlsruhe, Germany.
ORCID profiles: Friederike Holderried, Alessandra Sonanini, Christian Stegemann-Philipps, Anne Herrmann-Werner, Philipp Spitzer, Martina Guthoff, Nils Heyne, Konstantin Sering, Martin Holderried, Felix Eisinger
Cite
APA
Holderried, F., Sonanini, A., Stegemann-Philipps, C., Herrmann-Werner, A., Spitzer, P., Guthoff, M., Heyne, N., Sering, K., Holderried, M., & Eisinger, F. (2026). Impact of GPT-4–Generated Discharge Letters on Patients’ Medical Comprehension: Prospective Crossover Study. Journal of Medical Internet Research, 28, e81243. https://doi.org/10.2196/81243
Vancouver
Holderried F, Sonanini A, Stegemann-Philipps C, Herrmann-Werner A, Spitzer P, Guthoff M, et al. Impact of GPT-4–Generated Discharge Letters on Patients’ Medical Comprehension: Prospective Crossover Study. Journal of Medical Internet Research. 2026;28:e81243. doi:10.2196/81243
BibTeX
@article{Holderried2026,
author = {Holderried, Friederike and Sonanini, Alessandra and Stegemann-Philipps, Christian and Herrmann-Werner, Anne and Spitzer, Philipp and Guthoff, Martina and Heyne, Nils and Sering, Konstantin and Holderried, Martin and Eisinger, Felix},
title = {Impact of GPT-4–Generated Discharge Letters on Patients’ Medical Comprehension: Prospective Crossover Study},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e81243},
doi = {10.2196/81243}
}
EUVIMED